Healthcare -
Biotechnology - NASDAQ - GB
$ 1.38
0.362 %
$ 56.7 M
Market Cap
-0.83
P/E
ACHL - SHORT-TERM DEBT
Short-term Debt ACHL - Achilles Therapeutics plc
3.54 M
LAST VALUE
-11.14%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR